Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on February 18, 2014
[PR Newswire] – CRANBURY, N.J., Feb. 18, 2014 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases … moreView todays social media effects on PTNView the latest stocks trending across Twitter. Click to view dashboardSee who Palatin is hiring next, click here to view […]